Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-25-003009
Filing Date
2025-08-20
Accepted
2025-08-20 17:17:46
Documents
16
Effectiveness Date
2025-08-20

Document Format Files

Seq Description Document Type Size
1 S-8 zk2533683.htm S-8 75197
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 40897
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3261
4 exfilingfees.htm   iXBRL EX-FILING FEES 16067
5 image2.jpg GRAPHIC 617413
6 image00006.jpg GRAPHIC 4813
  Complete submission text file 0001178913-25-003009.txt   1111933

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4667
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289746 | Film No.: 251237742
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)